Theravax is an R&D startup that develops targeted, efficient, and stable virus platforms for oncolytic therapies. Its innovative pipeline leverages oncolytic adenoviruses to target and treat solid tumors. Among its developments, Caffe-1, a product for colorectal cancer, stands as the lead candidate in the pipeline.
Company Details
- Employees
- 1
- Address
- See All Employees
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://theravax.bio/
Theravax Questions
Theravax's website is https://theravax.bio/
Theravax's LinkedIn profile is https://www.linkedin.com/company/theravax
Theravax has
1 employees.
View email and phone details for 1
employees at Theravax.
Theravax's industry is
Biotechnology Research
Theravax's top competitors are
Mitophilix,
Synchrony,
St Innovative Diagnostics Ltd.,
Circa Therapeutics,
Metimedi Co., Ltd.,
Seal Biosciences,
Securitas Biosciences,
St-Diagnostic,
Epigenetic Data Sciences,
Chess Therapeutics, Llc.
Theravax's categories are Biotechnology Research
